Kaplan-Meier analyses of 0–5 year (early recurrence) and 5–10 year (late recurrence) disease-free survival (DFS) in patients with HR+/HER2- breast cancer.
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
Kaplan-Meier analyses of 0–5 year (early recurrence) and 5–10 year (late recurrence) disease-free survival (DFS) in patients with HR+/HER2- breast cancer.
创建时间：
2025-01-02
